𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Sequential hemibody and local irradiation with combination chemotherapy for small cell lung carcinoma: A preliminary analysis

✍ Scribed by Bayard L. Powell; Don V. Jackson Jr.; Charles W. Scarantino; Ellen Pope; Robert Choplin; Johnny B. Craig; James N. Atkins; M.Robert Cooper; Judith O. Hopkins; Renee McMahan; Hyman B. Muss; Frederick Richards II; John J. Stuart; Douglas R. White; Patricia Zekan; Charles L. Spurr; Robert L. Capizzi


Publisher
Elsevier Science
Year
1985
Tongue
English
Weight
790 KB
Volume
11
Category
Article
ISSN
0360-3016

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Combination radiotherapy and chemotherap
✍ Goldberg, R. S. ;Joss, R. A. ;Bedwinek, J. ;Yates, J. W. ;Krakoff, I. H. πŸ“‚ Article πŸ“… 1979 πŸ› John Wiley and Sons 🌐 English βš– 319 KB

Twenty previously untreated patients with small cell carcinoma of the lung were treated with cyclophosphamide, 400 mg/m2 and Adriamycin, 40 mg/m2 IV on day 1, followed by cytosine arabinoside, 20 mg/m2, every 12 hours subcutaneously on days 5--9; this regimen was repeated every 28 days. On days 14--

Alternating non-cross-resistant combinat
✍ R. S. Aroney; D. R. Bell; W. K. Chan; D. N. Dalley; J. A. Levi πŸ“‚ Article πŸ“… 1982 πŸ› John Wiley and Sons 🌐 English βš– 513 KB

The development of drug resistance limits the survival or patients with small cell anaplastic carcinoma of the lung (SCLC). The present study was undertaken to overcome this problem by administering two alternating noncross resistant combination chemotherapy regimens. One-hundred-one patients were e

Combination versus sequential single-age
✍ Niell, Harvey B. ;Griffin, John P. ;Hunter, Robert F. ;Meredith, Charlotte A. ;S πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 English βš– 716 KB

We have carried out a randomized phase Ill study in 105 patients with advanced nonsmall cell lung cancer, comparing a fourdrug cisplatin-mitomycin-based combination chemotherapy regimen t o sequential single-agent therapy. The combination chemotherapy regimen consisted of mitomycin C (10 mg/m2), vin